DCAT Annouces New Advisory Council Member Dr. Roberto Margarita

Oct 30, 2015
Robbinsville, NJ, USA > The Drug, Chemical & Associated Technology Association (DCAT) is pleased to announce that Dr. Roberto Margarita, Director, Global Antibiotics & Oncology Platforms at CordenPharma International has been elected by the membership to serve on DCAT’s Advisory Council for a three-year term beginning November 1, 2015. 

“We are pleased to have Dr. Margarita join the leadership of the organization,” said Executive Director Margaret M. Timony. “As the DCAT organization looks to further our mission, we welcome his global industry experience, energy and commitment.”

About DCAT
The Drug, Chemical & Associated Technologies Association (DCAT) powers relationships and industry knowledge for companies engaged in the business of pharmaceutical development and manufacturing. As a not-for-profit, member-supported global business development organization, DCAT is composed of pharmaceutical and biopharmaceutical companies and suppliers involved in the full spectrum of the manufacturing value chain. DCAT has been providing a life-long collegial community for industry representatives for over 125 years. DCAT has over 400 corporate members and is headquartered in Robbinsville, New Jersey.
Erin Sanders
Communications Coordinator